HPL Electric & Power Ltd., incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 1,995.89 Crore) operating in Consumer Durables sector. HPL Electric & Power Ltd. key ...

Abstract. Proteolysis-targeting chimeras (PROTAC) are bivalent molecules that simultaneously bind to proteins of interest and cellular ubiquitin E3 ligases to promote target degradation.

HPL Electric & Power Ltd. is a Public Limited Listed company incorporated on 28/05/1992 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is ...

HPL Electric & Power Limited is an India-based company, which is an electric equipment manufacturer. The Company offers low-voltage electrical solutions. It operates through two segments: Metering, ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

HPL Electric & Power Ltd reported a healthy operating performance in the December quarter, with growth across revenue, profit and margins on a year-on-year basis. For Q3, the company’s net profit ...

(UroToday.com) The 2023 ESMO annual meeting included a session on prostate cancer, featuring a presentation by Dr. Daniel Petrylak discussing radiographic progression-free survival (rPFS) in patients ...

(UroToday.com) The 2025 ESMO annual meeting featured a prostate cancer session and a presentation by Dr. Shun Zhang discussing a phase 1 study of QLH12016, an androgen receptor PROTAC degrader in ...